Clinical bottom line
Pediatric Eustachian tube dysfunction (ETD) remains a challenging condition with significant implications for middle ear health and hearing. Recent advancements emphasize minimally invasive endoscopic balloon Eustachian tuboplasty (BET) as a promising intervention for refractory cases, showing improved middle ear ventilation and symptom relief. However, evidence is still emerging regarding long-term efficacy, optimal patient selection, and procedural standardization. Clinicians should consider BET as an adjunct to medical management in carefully selected pediatric patients while remaining vigilant for potential complications and the need for further validation.
What the evidence shows
Eustachian tube dysfunction in children often manifests as chronic middle ear ventilation problems, leading to otitis media with effusion, retractions, and hearing loss (Grindle et al., 2020). Traditional management includes medical therapies and tympanostomy tubes, but these do not address underlying tubal dysfunction directly (Bal et al., 2022).
Recent literature highlights endoscopic balloon Eustachian tuboplasty (BET) as an emerging technique targeting the cartilaginous portion of the Eustachian tube to restore patency and function. Multiple studies report symptomatic improvement and objective measures of middle ear ventilation following BET in pediatric populations with chronic ETD refractory to medical therapy (Mishra et al., 2025; Jung et al., 2026). For example, Mishra et al. (2025) demonstrated that BET improved Eustachian tube function tests and reduced middle ear effusion rates in children, with a favorable safety profile. Jung et al. (2026) further support BET as a viable surgical option in pediatric patients, emphasizing its minimally invasive nature and potential to reduce reliance on tympanostomy tubes.
Historical perspectives and reviews underscore the evolution of BET from adult applications to pediatric use, noting anatomical and physiological differences that necessitate tailored approaches (Sudhoff et al., 2026; Taneja et al., 2018). Taneja et al. (2018) reported durable symptom relief in longstanding ETD cases treated with balloon tuboplasty, suggesting potential for modifying disease course.
Diagnostic advances, including endoscopic evaluation and functional testing, improve identification of candidates likely to benefit from BET (Boiko et al., 2025). However, differential diagnosis remains critical to exclude other causes of middle ear pathology (Boiko et al., 2025).
Caveats and uncertainty
While BET shows promise, current evidence is limited by small sample sizes, heterogeneous patient populations, and variable outcome measures. Long-term follow-up data in pediatric cohorts remain sparse, and the durability of symptom relief beyond 1–2 years is not well established (Mishra et al., 2025; Jung et al., 2026).
Patient selection criteria are not yet standardized, and the procedure’s efficacy in younger children or those with craniofacial anomalies requires further study (Bal et al., 2022). Procedural techniques vary, including balloon size, inflation pressure, and duration, complicating direct comparisons across studies (Mishra et al., 2025).
Potential complications, though infrequent, include mucosal injury, bleeding, and rarely, carotid artery injury due to anatomical proximity, underscoring the need for careful endoscopic visualization and surgical expertise (Jung et al., 2026).
Finally, BET should not be viewed as a standalone cure but rather as part of a comprehensive management strategy including medical therapy and surveillance (Bal et al., 2022).
How this may change practice
The integration of endoscopic balloon Eustachian tuboplasty into pediatric otolaryngology offers a targeted approach to ETD that may reduce the need for repeated tympanostomy tubes and improve quality of life. Clinicians should consider BET for children with persistent ETD symptoms despite optimal medical management, particularly when traditional interventions fail or are contraindicated.
Adoption of BET requires appropriate training in endoscopic techniques and patient selection informed by evolving diagnostic criteria. Multidisciplinary collaboration with audiology and radiology can enhance assessment and follow-up.
Future practice may incorporate BET earlier in the treatment algorithm as evidence matures, potentially shifting paradigms from symptomatic management to functional restoration of the Eustachian tube.
Ongoing research and clinical trials are essential to refine indications, optimize procedural protocols, and establish long-term safety and efficacy benchmarks.